Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-23T20:37:40.967Z Has data issue: false hasContentIssue false

Long-term outcome after atrioventricular valve surgery following modified Fontan operation

Published online by Cambridge University Press:  27 October 2010

Shaji C. Menon*
Affiliation:
Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
Joseph A. Dearani
Affiliation:
Division of Cardiothoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota, United States of America
Frank Cetta
Affiliation:
Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, United States of America Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America
*
Correspondence to: Dr S. C. Menon, MD, Pediatric Cardiology, 100 N. Mario Capechhi Drive, Salt Lake City, Utah 84113, United States of America. Tel: 801 662 5400; Fax: 801 662 5404; E-mail: shaji.menon@utah.edu

Abstract

Objective

The objective of this study was to evaluate the early and late results of atrioventricular valve surgery after Fontan operation.

Background

Atrioventricular valve regurgitation is a known perioperative risk factor for Fontan operation. There are limited data on the outcomes of late atrioventricular valve surgery following Fontan operation.

Methods

Patients who underwent atrioventricular valve surgery following Fontan procedure were identified from the Mayo Clinic Fontan database. Medical records were reviewed for pre-operative, operative, and post-operative clinical and haemodynamic data. All patients not known to be deceased were sent health status questionnaires.

Results

A total of 61 patients (28 females) underwent atrioventricular valve surgery following Fontan procedure. The median age at atrioventricular valve surgery was 14 years. The median duration between Fontan and atrioventricular valve surgery was 4.7 years. Median follow-up was 9 years. There were a total of 32 (52%) deaths with 8 (13%) within 30 days of surgery. The 5-, 10-, and 15-year survival rates were 67%, 57%, and 45%, respectively. On follow-up, 44 of 61 (72%) had arrhythmias, 21 of 29 (72%) were symptomatic, and 12 of 61 (20%) developed protein-losing enteropathy. On multivariate analysis, reduced ventricular function and development of protein-losing enteropathy were associated with decreased survival.

Conclusion

Atrioventricular valve surgery after Fontan procedure is associated with substantial late morbidity and mortality. Atrioventricular valve surgery in this cohort of patients portends poor long-term outcome and is associated with a high incidence of protein-losing enteropathy. Reduced ventricular function and development of protein-losing enteropathy were associated with decreased survival.

Type
Original Articles
Copyright
Copyright © Cambridge University Press 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Fontan, F, Baudet, E. Surgical repair of tricuspid atresia. Thorax 1971; 26: 240258.CrossRefGoogle ScholarPubMed
2. Khairy, P, Fernandes, SM, Mayer, JE Jr, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 2008; 117: 8592.CrossRefGoogle ScholarPubMed
3. Kerendi, F, Kramer, ZB, Mahle, WT, et al. Perioperative risks and outcomes of atrioventricular valve surgery in conjunction with Fontan procedure. Ann Thorac Surg 2009; 87: 14881489.CrossRefGoogle ScholarPubMed
4. Hirsch, JC, Goldberg, C, Bove, EL, et al. Fontan operation in the current era: a 15-year single institution experience. Ann Surg 2008; 248: 402410.CrossRefGoogle Scholar
5. Anderson, PA, Sleeper, LA, Mahony, L, et al. Pediatric heart network investigators. Contemporary outcomes after the Fontan procedure: a pediatric heart network multicenter study. J Am Coll Cardiol 2008; 52: 8598.CrossRefGoogle ScholarPubMed
6. Hosein, RB, Clarke, AJ, McGuirk, SP, et al. Factors influencing early and late outcome following the Fontan procedure in the current era. The ‘Two Commandments’? Eur J Cardiothorac Surg 2007; 31: 344352.CrossRefGoogle ScholarPubMed
7. Khairy, P, Poirier, NC, Mercier, LA. Univentricular heart. Circulation 2007; 115: 800912.CrossRefGoogle ScholarPubMed
8. Driscoll, DJ, Oxfford, KP, Feldt, RH, et al. 5–15 year follow-up after Fontan operation. Circulation 1992; 85: 469496.CrossRefGoogle Scholar
9. Bartz, PJ, Driscoll, DJ, Dearani, JA, et al. Early and late results of the modified fontan operation for heterotaxy syndrome 30 years of experience in 142 patients. J Am Coll Cardiol 2006; 48: 23012305.CrossRefGoogle ScholarPubMed
10. Gentles, TL, Mayer, JE Jr, Gauvreau, K, et al. Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. J Thorac Cardiovasc Surg 1997; 114: 376391.CrossRefGoogle ScholarPubMed
11. Humes, RA, Feldt, RH, Porter, CJ, et al. The modified Fontan operation for asplenia and polysplenia syndromes. J Thorac Cardiovasc Surg 1988; 96: 212218.CrossRefGoogle ScholarPubMed
12. Earing, MG, Cetta, F, Driscoll, DJ, et al. Long-term results of the Fontan operation for double-inlet left ventricle. Am J Cardiol 2005; 96: 291298.CrossRefGoogle ScholarPubMed
13. Mair, DD, Puga, FJ, Danielson, GK. The Fontan procedure for tricuspid atresia: early and late results of a 25-year experience with 216 patients. J Am Coll Cardiol 2001; 37: 933939.CrossRefGoogle ScholarPubMed
14. Cetta, F, Feldt, RH, O’Leary, PW, et al. Improved early morbidity and mortality after Fontan operation: the Mayo clinic experience, 1987 to 1992. J Am Coll Cardiol 1996; 28: 480486.CrossRefGoogle Scholar
15. Choussat, A, Fontan, F, Besse, P, et al. Selection criteria for Fontan procedure. In: Anderson RH, Shinebourne EA, editor. Pediatric Cardiology. Churchill Livingstone, Edinburg, 1978, 559566.Google Scholar
16. d’Udekem, Y, Iyengar, AJ, Cochrane, AD, et al. The Fontan procedure: contemporary techniques have improved long-term outcomes. Circulation 2007; 116: I157164.CrossRefGoogle ScholarPubMed
17. Gersony, WM. Fontan operation after 3 decades: what we have learned. Circulation 2008; 117: 1315.CrossRefGoogle ScholarPubMed
18. Knott-Craig, CJ, Danielson, GK, Schaff, HV, et al. The modified Fontan operation. An analysis of risk factors for early postoperative death or takedown in 702 consecutive patients from one institution. J Thorac Cardiovasc Surg 1995; 109: 12371243.CrossRefGoogle ScholarPubMed
19. Lamberti, JJ, Mainwaring, RD, Spicer, RL, et al. Factors influencing perioperative morbidity during palliation of the univentricular heart. Ann Thorac Surg 1995; 60: S550S553.CrossRefGoogle ScholarPubMed
20. Imai, Y, Takanashi, Y, Hoshino, S, et al. Modified Fontan procedure in ninety-nine cases of atrioventricular valve regurgitation. J Thorac Cardiovasc Surg 1997; 113: 262268.CrossRefGoogle ScholarPubMed
21. Uemura, HYT, Kawashima, Y, Yamamoto, F, et al. What factors affect ventricular performance after a Fontan-type operation? J Thorac Cardiovasc Surg 1995; 110: 405415.CrossRefGoogle ScholarPubMed
22. Reyes, A 2nd, Bove, EL, Mosca, RS, et al. Tricuspid valve repair in children with hypoplastic left heart syndrome during staged surgical reconstruction. Circulation 1997; 96: II344II345.Google ScholarPubMed
23. Sallehuddin, A, Bulbul, Z, Otero, F, et al. Repair of atrioventricular valve regurgitation in the modified Fontan operation. Eur J Cardiothorac Surg 2004; 26: 5459.CrossRefGoogle ScholarPubMed
24. Rychik, J. Forty years of the Fontan operation: a failed strategy. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2010; 13: 96100.CrossRefGoogle ScholarPubMed